The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New prices aim to save billions by 2027. Vandana Singh Qorvo Soars 7% After ...

Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...

The company has a forward P/E ratio of 11.5 while Merck, Eli Lilly, and Novo Nordisk have multiples of 14.8, 64, and 40.5.

Below is a chart showing PFE's trailing twelve month trading history, with the $27.00 strike highlighted in red: Considering the fact that the $27.00 strike represents an approximate 1% premium to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Below is a chart showing PFE's trailing twelve month trading history, with the $27.00 strike highlighted in red: Considering the fact that the $27.00 strike represents an approximate 1% premium to ...

Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer (PFE – Research Report) and keeping the price target at $36.00. Discover outperforming stocks and invest smarter with ...